Antazoline with Xylometazoline
Brand names: Otrivine-Antistin
Antazoline with xylometazoline is a topical ocular preparation combining an antihistamine with a sympathomimetic vasoconstrictor, used for short-term relief of allergic conjunctivitis.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
Antazoline blocks histamine H1 receptors to reduce itch and inflammation, while xylometazoline stimulates alpha-adrenergic receptors to constrict conjunctival vessels and reduce redness.
Prescribing in practice
- Avoid in untreated angle-closure (narrow-angle) glaucoma, as the sympathomimetic component can precipitate an acute attack.
- Limit to short-term use, as prolonged application of the vasoconstrictor can cause rebound conjunctival hyperaemia.
- Use with caution in patients with cardiovascular disease, hypertension or hyperthyroidism.
Monitoring
Monitor symptomatically for resolution of allergic signs and for rebound redness with continued or prolonged use.
Counselling the patient
- Use for only a few days; if symptoms persist, seek further review.
- Remove contact lenses before instilling drops.
- Transient stinging and pupil changes can occur after instillation.
Evidence & guidelines
Combined antihistamine-decongestant eye drops provide established short-term symptomatic relief in allergic conjunctivitis as reflected in current prescribing references.
Reference: NICE CKS Conjunctivitis — allergic (2023); RCOphth patient information; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Acute Red Eye / Vision Loss Screen · RCOphth 2020; NICE CKS
- Idiopathic Intracranial Hypertension · ABN; consensus 2018
- Acute Red Eye Assessment · RCOphth / AAO
- Acute Angle Closure Glaucoma · RCOphth / EGS Guidelines
- Retinal Detachment · RCOphth Guidelines / EURETINA
- Diabetic Retinopathy — Screening and Management · NICE NG28 2016 / NHS DES Programme